We intend to capitalize on our management team’s background and experience to identify promising opportunities in the biotechnology and life science infrastructure sector.

We were co-founded by Foresite Capital Management, LLC, an investment firm with approximately $3.5 billion in assets under management as of Dec. 31, 2020 (“Foresite Capital”) and Jim Tananbaum, our President, Chief Executive Officer and a director. Foresite Capital, which is a member of our sponsor and is our affiliate, was established in 2011 by Jim Tananbaum and has been focused on therapeutic companies within the biotechnology sector.

(Note: FS Development Corp. II further upsized its IPO at pricing on Feb. 16, 2021, to 17.5 million shares, up from 15 million, at $10 each to raise $175 million. The blank-check company’s initial size was 10 million shares, and that amount was raised to 15 million in an S-1/A filing dated Feb. 9, 2021. This underwriting  was incorporated in Delaware.)